|
Volumn 359, Issue 9323, 2002, Pages 2105-2107
|
Differential pricing of drugs: A role for cost-effectiveness analysis?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACERIL;
ALAPRIL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
EDNIT;
ENALAPRIL;
ENALAPRIL MALEATE;
ENAP 20;
ENAP KRKA;
ENAPIREX;
HYDROCHLOROTHIAZIDE;
INVORIL;
IRUMED;
LISINOPRIL;
THIAZIDE DIURETIC AGENT;
VASOPREN;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
ECONOMIC ASPECT;
HEALTH CARE;
HEART LEFT VENTRICLE FAILURE;
HUMAN;
HYPERTENSION;
PRIORITY JOURNAL;
SHORT SURVEY;
SURVIVAL;
TECHNIQUE;
|
EID: 0037097042
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(02)08911-0 Document Type: Article |
Times cited : (30)
|
References (19)
|